Christopher Abbott

No más puestos en curso

Fortuna: 17 M $ al 31/03/2024

Health Technology

Finance

Commercial Services

Perfil

Christopher M.
Abbott was the Chairman-Emeritus and founder of Genetic Signatures Ltd.
Dr. Abbott is also the founder of Peplin Ltd., Maple-Brown Abbott Ltd.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
GENETIC SIGNATURES LTD. 20.59%	28/08/2023	38 392 200 ( 20.59% )	17 M $	31/03/2024

Antiguos cargos conocidos de Christopher Abbott.

Empresas	Cargo	Fin
Maple-Brown Abbott Ltd. Maple-Brown Abbott Ltd. Investment ManagersFinance Maple-Brown Abbott Ltd. (MBA) is an investment management firm headquartered in Sydney, Australia. The firm was founded by Robert Maple-Brown and Chris Abbott in 1984. They are a subsidiary of Maple-Brown Family Investments Pty Ltd. The firm offers Australian managed investment schemes, UCITS (Undertaking for Collective Investment in Transferable Securities) funds in a variety of currencies and discrete mandates to clients around the world. Their clients include superannuation funds, financial institutions, endowments, charities, family offices, financial advisers, wholesale investors and retail investors. MBA is a socially responsible investor and a signatory to the UN Principles for Responsible Investment (UNPRI).	Founder	-
Peplin Ltd. Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia	Founder	-
GENETIC SIGNATURES LIMITED	Founder	-

Ver el detalle de la experiencia de Christopher Abbott.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas